Compare LSF & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSF | QTTB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 25.1M |
| IPO Year | 2020 | N/A |
| Metric | LSF | QTTB |
|---|---|---|
| Price | $2.31 | $3.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | $12.00 | ★ $12.17 |
| AVG Volume (30 Days) | 118.3K | ★ 8.9M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,146,862.00 | N/A |
| Revenue This Year | $18.05 | N/A |
| Revenue Next Year | $17.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | N/A |
| 52 Week Low | $2.18 | $1.35 |
| 52 Week High | $8.99 | $27.61 |
| Indicator | LSF | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 28.90 | 62.78 |
| Support Level | $2.18 | $3.23 |
| Resistance Level | $2.78 | $3.96 |
| Average True Range (ATR) | 0.19 | 0.48 |
| MACD | 0.05 | 0.15 |
| Stochastic Oscillator | 27.67 | 35.16 |
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.